Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience

Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience

Abstract Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2 infection, which evolved into a global pandemic within a short time. Individuals with sickle cell disease (SCD) suffer from underlying cardiopulmonary comorbidities and are at risk of severe complications such as pneumonia, acute c...

Full description

Bibliographic Details
Main Authors: Preethi Ramachandran, Abhilash Perisetti, Balachandar Kathirvelu, Mahesh Gajendran, Snigdha Ghanta, Ifeanyichkwu Onukogu, Ted Lao, Faiz Anwer
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:eJHaem
Subjects:
anemia
general hematology
hematological oncology
hemoglobin disorders
sickle cell disease
Online Access:https://doi.org/10.1002/jha2.87

Internet

https://doi.org/10.1002/jha2.87

Similar Items